American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed Amendment No. 3 to a Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership position in Enovis Corporation as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: The three reporting persons each reported beneficial ownership of 6,889,905 shares of Enovis Corporation common stock, representing 12.0% of the class.
- Sole voting power: Each reporting person listed sole voting power over 6,634,176 shares, with no shared voting power reported.
- Sole dispositive power: Each reporting person listed sole dispositive power over 6,889,905 shares, with no shared dispositive power reported.
- Triggering event date: The date of the event requiring this filing was September 30, 2026, according to the document.
- Corporate structure: The filing states that American Century Investment Management, Inc. is a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.
- No single client exceeds 5%: The filing states that no single client advised by American Century Investment Management, Inc. owns more than 5% of the class of securities subject to this schedule.
American Century and Stowers Institute Disclose Joint 12.0% Position in Enovis Corporation
According to the filing, American Century Investment Management, Inc. (ACIM), American Century Companies, Inc. (ACC), and Stowers Institute for Medical Research jointly submitted Amendment No. 3 to Schedule 13G regarding their holdings in Enovis Corporation, whose common stock is listed on NYSE:ENOV. The issuer's principal executive offices are located at 2900 Lake Vista Drive, Suite 200, Lewisville, Texas, 75067, and the reporting persons are based at 4500 Main Street, 9th Floor, Kansas City, Missouri 64111. All three filers are organized under the laws of Delaware.
The filing reports that each of the three entities beneficially owns 6,889,905 shares of Enovis common stock, equal to 12.0% of the outstanding class. Each entity reported sole voting power over 6,634,176 shares and sole dispositive power over 6,889,905 shares. The filing discloses shared voting power and shared dispositive power of 0.00 for each reporting person. The document identifies ACIM as an investment adviser (Type: IA), ACC as a holding company (Type: HC), and Stowers Institute for Medical Research as a holding company (Type: HC).
The filing further states that "various persons, including the investment companies and separate institutional investor accounts" that ACIM serves as investment adviser "have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule." It also certifies, as required, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
What Was Disclosed
Three affiliated entities - American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research - filed Amendment No. 3 to Schedule 13G reporting combined beneficial ownership of 6,889,905 shares, or 12.0%, of Enovis Corporation common stock as of September 30, 2026.



Please wait processing your request...